Biochemical and antitumor effects of the combination of thymidine and 1-beta-D-arabinofuranosylcytosine against leukemia L1210.
D000818:Animals; D001085:Arabinofuranosylcytosine Triphosphate / Q000378:metabolism; D001224:Aspartic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives; D002478:Cells, Cultured; D003561:Cytarabine / Q000008:administration & dosage* / Q000633:toxicity; D003562:Cytidine / Q000494:pharmacology; D004359:Drug Therapy, Combination; D007939:Leukemia L1210 / Q000188:drug therapy* / Q000378:metabolism; D051379:Mice; D010746:Phosphonoacetic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives; D013936:Thymidine / Q000008:administration & dosage* / Q000037:antagonists & inhibitors
D003561:Cytarabine; D001085:Arabinofuranosylcytosine Triphosphate; D001224:Aspartic Acid; D003562:Cytidine; C013195:sparfosic acid; D010746:Phosphonoacetic Acid; D013936:Thymidine